Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

RE: Joentausta et al. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583-591.

Kawada T.

Prostate. 2019 Sep;79(12):1399. doi: 10.1002/pros.23862. Epub 2019 Jul 23. No abstract available.

PMID:
31334855
2.

Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort. Prostate. 2019;79:583-591.

Joentausta RM, Murtola TJ.

Prostate. 2019 Sep;79(12):1420-1421. doi: 10.1002/pros.23870. Epub 2019 Jun 24. No abstract available.

PMID:
31233216
3.

Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.

Joentausta RM, Rannikko A, Murtola TJ.

Prostate. 2019 May;79(6):583-591. doi: 10.1002/pros.23768. Epub 2019 Jan 16.

PMID:
30652328
4.

Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study.

Cattarino S, Seisen T, Drouin SJ, Renard-Penna R, Leon P, Comperat E, Mozer P, Cussenot O, Rouprêt M.

Can J Urol. 2015 Apr;22(2):7703-8.

PMID:
25891333
5.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
6.

Statin use and risk of disease recurrence and death after radical prostatectomy.

Keskiväli T, Kujala P, Visakorpi T, Tammela TL, Murtola TJ.

Prostate. 2016 Apr;76(5):469-78. doi: 10.1002/pros.23138. Epub 2015 Dec 22.

PMID:
26689439
7.

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

Murtola TJ, Tammela TL, Määttänen L, Huhtala H, Platz EA, Ala-Opas M, Stenman UH, Auvinen A.

Int J Cancer. 2010 Oct 1;127(7):1650-9. doi: 10.1002/ijc.25165.

8.

Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis.

Mass AY, Agalliu I, Laze J, Lepor H.

J Urol. 2012 Sep;188(3):786-91. doi: 10.1016/j.juro.2012.05.011. Epub 2012 Jul 19.

PMID:
22818136
9.

Effect of statin use on biochemical outcome following radical prostatectomy.

Ritch CR, Hruby G, Badani KK, Benson MC, McKiernan JM.

BJU Int. 2011 Oct;108(8 Pt 2):E211-6. doi: 10.1111/j.1464-410X.2011.10159.x. Epub 2011 Mar 31.

10.

Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer.

Song C, Park S, Park J, Shim M, Kim A, Jeong IG, Hong JH, Kim CS, Ahn H.

Prostate. 2015 Feb;75(2):211-7. doi: 10.1002/pros.22907. Epub 2014 Oct 18.

PMID:
25327522
11.

Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy.

Bañez LL, Klink JC, Jayachandran J, Lark AL, Gerber L, Hamilton RJ, Masko EM, Vollmer RT, Freedland SJ.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):722-8. doi: 10.1158/1055-9965.EPI-09-1074. Epub 2010 Feb 16.

12.

Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.

Hamilton RJ, Banez LL, Aronson WJ, Terris MK, Platz EA, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ.

Cancer. 2010 Jul 15;116(14):3389-98. doi: 10.1002/cncr.25308.

13.

Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.

Ishak-Howard MB, Okoth LA, Cooney KA.

Urology. 2014 Jun;83(6):1356-61. doi: 10.1016/j.urology.2014.02.015. Epub 2014 Apr 16.

14.

Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.

BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.

15.

Is statin use associated with prostate cancer aggressiveness?

Loeb S, Kan D, Helfand BT, Nadler RB, Catalona WJ.

BJU Int. 2010 May;105(9):1222-5. doi: 10.1111/j.1464-410X.2009.09007.x. Epub 2009 Nov 3.

16.

Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen.

Krane LS, Kaul SA, Stricker HJ, Peabody JO, Menon M, Agarwal PK.

J Urol. 2010 Jan;183(1):118-24. doi: 10.1016/j.juro.2009.08.151.

PMID:
19913252
17.

Impact of HMG-CoA reductase inhibitor (statin) use on blood loss during robot-assisted and open radical prostatectomy.

Truesdale MD, Polland AR, Graversen JA, Sartori S, Hruby GW, Landman J, McKiernan JM, Benson MC, Badani KK.

J Endourol. 2011 Sep;25(9):1427-33. doi: 10.1089/end.2010.0688. Epub 2011 Jul 28.

PMID:
21797762
18.

Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ.

BJU Int. 2014 Nov;114(5):661-6. doi: 10.1111/bju.12720. Epub 2014 May 8.

19.

Does statin use affect the risk of developing prostate cancer?

Platz EA.

Nat Clin Pract Urol. 2009 Feb;6(2):70-1. doi: 10.1038/ncpuro1295. Epub 2009 Jan 20.

PMID:
19153570
20.

Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.

Lyon TD, Turner RM 2nd, Yabes JG, Woldemichael E, Davies BJ, Jacobs BL, Nelson JB.

Urology. 2016 Nov;97:153-159. doi: 10.1016/j.urology.2016.08.004. Epub 2016 Aug 8.

PMID:
27516122

Supplemental Content

Support Center